HIV-1 gp120 V3 Loop for Structure-Based Drug Design

By  

Current Protein and Peptide Science, Vol. 6, Iss. 5, 2005-10 ,pp. : 413-422

Bentham Science Publishers

Access to resources Recommend Favorite

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase

By Li Na   Wang Yuxuan   Pothukuchy Arti   Syrett Angel   Husain Naeem   Gopalakrisha Siddharth   Kosaraju Pradeepa   Ellington Andrew D.  

Nucleic Acids Research, Vol. 37, Iss. 15, 2009-08 ,pp. : 5236-5236

Oxford University Press

Access to resources Recommend Favorite

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase

By Li Na   Wang Yuxuan   Pothukuchy Arti   Syrett Angel   Husain Naeem   Gopalakrisha Siddharth   Kosaraju Pradeepa   Ellington Andrew D.  

Nucleic Acids Research, Vol. 36, Iss. 21, 2008-12 ,pp. : 6739-6751

Oxford University Press

Access to resources Recommend Favorite

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors

By Famiglini Valeria   Coluccia Antonio   Brancale Andrea   Pelliccia Sveva   La Regina Giuseppe   Silvestri Romano  

Future Medicinal Chemistry, Vol. 5, Iss. 18, 2013-12 ,pp. : 2141-2156

Future Science

Access to resources Recommend Favorite

Structures of Tyr188Leu Mutant and Wild-type HIV-1 Reverse Transcriptase Complexed with the Non-nucleoside Inhibitor HBY 097: Inhibitor Flexibility is a Useful Design Feature for Reducing Drug Resistance

By Hsiou Y.   Das K.   Ding J.   Clark Jr A.D.   Kleim J-P.   Rösner M.   Winkler I.   Riess G.   Hughes S.H.   Arnold E.  

Journal of Molecular Biology, Vol. 284, Iss. 2, 1998-11 ,pp. : 313-323

Academic Press

Access to resources Recommend Favorite